Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Agilent is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- EFFECT2026-09-23EFFECT
- 424B32026-09-23424B3
- 8-K2026-09-08Current report (material event)
- S-42026-09-01S-4
- S-3ASR2026-09-01S-3ASR
- 10-Q2026-09-01Quarterly report
- 8-K2026-08-26Current report (material event)
- 8-K2026-06-25Current report (material event)
- 10-Q2026-06-01Quarterly report
- SD2026-05-29SD
- 8-K2026-05-27Current report (material event)
- 8-K2026-05-04Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G2026-04-28SCHEDULE 13G
- 8-K/A2026-04-06Current report (amended)
- 8-K2026-04-03Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-20Current report (material event)
- 8-K2026-03-06Current report (material event)
- 10-Q2026-03-03Quarterly report
- 8-K2026-02-25Current report (material event)
- DEFA14A2026-02-06DEFA14A
- ARS2026-02-06Annual report to holders
- DEF 14A2026-02-06Proxy statement
- PRE 14A2026-01-23PRE 14A
- 10-K2025-12-22Annual report
- 8-K2025-11-24Current report (material event)
- 8-K2025-10-27Current report (material event)
- 10-Q2025-08-29Quarterly report
- 8-K2025-08-27Current report (material event)
- 8-K/A2025-08-08Current report (amended)
- 8-K2025-07-15Current report (material event)
- 10-Q2025-06-02Quarterly report
- 8-K2025-05-28Current report (material event)
- SD2025-05-27SD
- 8-K2025-05-21Current report (material event)
- 8-K2025-05-02Current report (material event)
- SCHEDULE 13G/A2025-04-17SCHEDULE 13G/A
- 8-K2025-04-02Current report (material event)
- 8-K2025-03-17Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.